Danube AG

DSFIR

CH1216478797

Consumer Goods Conglomerates

End-of-day quote Euronext Amsterdam Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
105.3 ^CHF	+2.53%		+1.15%	+14.46%

Apr. 11	U.S. Futures Down, European Stocks Mixed	DJ
Apr. 08	DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital.	CI

Danube : DSM-Firmenich AG, - dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China

March 08, 2024 at 04:23 am EST

DSM-Firmenich AG

DSM-Firmenich AG

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

Registration date08 mar 2024 - 07:29

Statutory nameDSM-Firmenich AG

Titledsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China

Previous result

Next result

Related downloads

202403080000000001_Press release_dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China_20240308.docx(opens in a new window)

202403080000000001_Press release_dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China_20240308.pdf(opens in a new window)

Date last update: 08 March 2024

Attachments

Original Link
Permalink

Disclaimer

DSM-Firmenich AG published this content on 08 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 March 2024 09:22:04 UTC.

Latest news about Danube AG

U.S. Futures Down, European Stocks Mixed	Apr. 11	DJ
DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital.	Apr. 08	CI
DSM-Firmenich AG authorizes a Buyback Plan.	Apr. 07	CI
DSM-FIRMENICH : A stronger long-term outlook	Apr. 05
Quiz sales fall, names new CEO; Byotrol eyes AIM exit	Apr. 03	AN
Quotes from Dutch companies on the worsening business climate	Mar. 12	RE
ASML's threat to leave uncovers deeper concerns in Netherlands Inc.	Mar. 12	RE
DSM-Firmenich Completes Sale of Vitamin C Plant in China	Mar. 08	MT
Jingjiang Cosfocus Health Technology Co., Ltd. acquired DSM Jiangshan Pharmaceutical Co., Ltd from DSM-Firmenich AG.	Mar. 07	CI
Philips: Chairman to seek second term	Feb. 20	CF
DSM-FIRMENICH : Some mess from the combination	Feb. 16
Global markets live: Airbus, Cisco, BAE, Salesforce, Deere...	Feb. 15
FTSE 100 Closes Up As Investors Shrug Off Recession Confirmation	Feb. 15	DJ
DSM-FIRMENICH : An even pure(er) play	Feb. 15
DSM-Firmenich Plans to Spinoff Pet Care Business	Feb. 15	CI
Dsm-firmenich Plans Pharmacokinetic Trial for New Cannabidiol Formulation With Zerion Pharma	Feb. 15	MT
Transcript : DSM-Firmenich AG, 2023 Earnings Call, Feb 15, 2024	Feb. 15
Dsm-firmenich to Carve Out Animal Nutrition Business	Feb. 15	MT
DSM Firmenich plans to separate animal nutrition and health unit	Feb. 15	RE
DSM-Firmenich AG Proposes Dividend for the Financial Year 2023	Feb. 15	CI
DSM-Firmenich AG Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 14	CI
Global markets live: TUI, Coca-Cola, Biogen, ARM Holdings, Glencore...	Feb. 13
DSM-Firmenich Amasses 98.5% Stake in DSM With Voluntary Tender Offer	Feb. 12	MT
British antitrust watchdog expands investigation into fragrance manufacturers	Jan. 17	DP
DSM-Firmenich Offers to Expedite Buy-out of Remaining DSM Shares	Jan. 08	MT

Chart Danube AG

Duration

Period

More charts

Company Profile

DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.

Sector

Consumer Goods Conglomerates

Calendar

2024-05-02 - Q1 2024 Sales and Revenue Release - Trading Update

Related indices

STOXX EUROPE 600 (EUR) , AEX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DSM-FIRMENICH : A stronger long-term outlook

April 05, 2024 at 05:50 am EDT

More Strategies

Ratings for Danube AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

105.3 EUR

Average target price

119.5 EUR

Spread / Average Target

+13.47%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Consumer Goods Conglomerates

	1st Jan change	Capi.
DANUBE AG	+14.46%	29.82B
BERKSHIRE HATHAWAY INC.	+11.85%	869B
INTERNATIONAL HOLDING COMPANY	0.00%	239B
GE AEROSPACE	+27.20%	178B
HONEYWELL INTERNATIONAL INC.	-7.75%	126B
ILLINOIS TOOL WORKS INC.	-5.21%	74.17B
3M COMPANY	-16.00%	50.82B
ALPHA DHABI HOLDING	-24.57%	38.6B
MITSUBISHI ELECTRIC CORPORATION	+19.71%	31.74B
MITSUBISHI HEAVY INDUSTRIES, LTD.	+63.27%	28.73B

Consumer Goods Conglomerates

Danube AG

Equities

DSFIR

CH1216478797

Consumer Goods Conglomerates

Danube : DSM-Firmenich AG, - dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China

EPS Revisions